A Modified MELD Model for Chinese Pre-ACLF and ACLF Patients and It Reveals Poor Prognosis in Pre-ACLF Patients

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Xia, Qi ^a   Dai, Xiahong ^a   Zhang, Yimin ^a   Guo, Yongzheng ^a   Xu, Xiaowei ^a   Yang, Qian ^a   Du, Weibo ^a   Liu, Xiaoli ^a   Chen, Yuemei ^a   Huang, Jianrong ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; SODIUM; TRIACYLGLYCEROL;

ACUTE ON CHRONIC LIVER FAILURE; AGE; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OBSERVATIONAL STUDY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; ACUTE LIVER FAILURE; ADULT; CHINA; END STAGE LIVER DISEASE; FEMALE; HEPATITIS B; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ADULT; CHINA; END STAGE LIVER DISEASE; FEMALE; HEPATITIS B, CHRONIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84878769300     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064379     Document Type: Article

References (28)

1. Katoonizadeh A, Laleman W, Verslype C, Wilmer A, Maleux G, et al. (2010) Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 59: 1561-1569.
2. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA (2012) A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality. Liver International; Mar 19.doi:10.1111/j.1478-3231.2012.02790.x [Epub ahead of print].
3. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, (1973) Transection of the esophagus for bleeding oesophageal varices. Br J Surg 60: 646-649.
4. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31: 864-871.
5. Biggins SW, Kim WR, Terrauh NA, Saab S, Balan V, et a1 (2006) Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology130: 1652-1660.
6. Zheng MH, Shi KQ, Fan YC, Li H, Ye C, et al. (2011) A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol 9: 351-356.
7. Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, et al. (2009) Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepatitis16: 464-470.
8. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 26: 41-44.
9. Liver Failure and Artificial Liver Group, Chinese Medical Association & Severe Liver Diseases and Artificial Liver Group, Chinese Medical Association (2006) Diagnostic and treatment guidelines for liver failure. Zhonghua Gan Zang Bing Za Zhi14: 643-646.
10. Van den Besselarr AM, (1996) Precision and accuracy of the international normalized ratio in oral anticoagulant control. Haemostasis 26: 248-265.
11. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, et al. (2002) Hepatic Encephalopathy-Definition, Nomenclature, Diagnosis, and Quantification: Final Report of the Working Party at the 11th World Congresses of Gastroenterology. Hepatology 35: 716-721.
12. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, et al. (1977) Comparison of lactulose and neomycin in the treatment of chronic portosystemic encephalopathy. A double-blind controlled trial. Gastroenterology 72:5 73-583.
13. Cox DR, (1972) Regression models and life-tables. J R Stat Soc 34: 187-202.
14. Harrington DP, Fleming TR, (1982) A class of rank test procedures for censored survival data. Biometrika 69: 553-566.
15. Kaplan EL, Meier P, (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481.
16. Huang K, Hu JH, Wang HF, He WP, Chen J, et al. (2011) Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 17: 3448-3452.
17. Yu JW, Wang GQ, Li SC, (2006) Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol 21: 1519-1524.
18. Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY, (2007) Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Transpl Proc 39: 1501-1504.
19. Garg H, Kumar A, Garg V, Sharma P, Sharma BC, et al. (2012) Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis 44: 166-171.
20. Xu ZH, Ren XQ, Liu Y, Li X, Bai S, et al. (2011) Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol 46: 391-400.
21. Said A, Williams J, Holden J, Remington P, Gangnon R, et al. (2004) Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 40: 897-903.
22. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, et al. (2004) Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40: 802-810.
23. Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, et al. (2011) Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 53: 774-780.
24. Wiles A, Woodward JM, (2009) Recent advances in the management of intestinal failure-associated liver disease. Curr Opin Clin Nutr Metab Care12: 265-272.
25. Cottrell DB, Asturi E, (2004) Gastric intubation: assessment and intervention. Crit Care Nurs Clin N Am 16: 489-493.
26. O'Brien A, Williams R, (2008) Nutrition in end-stage liver disease: principles and practice. Gastroenterology134: 1729-1740.
27. Cabre E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, et a1 (1990) Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhosis cirrhotics. A randomized controlled trial. Gastroenterology 98: 715-720.
28. Kondrup J, Muller MJ, (1997) Energy and protein requirements of patients with chronic liver disease. J Hepatol 27: 239-247.